OverviewChartNewsTraderScreen

UC INLINE.WAR. 03/25 AMD/  DE000HD9B1J2  /

gettex Zertifikate
2025-01-06  7:46:41 PM Chg.+0.640 Bid9:32:39 PM Ask9:32:39 PM Underlying Strike price Expiration date Option type
5.910EUR +12.14% 5.860
Bid Size: 4,000		 5.920
Ask Size: 4,000		 Advanced Micro Devic... - USD 2025-03-19 Call
TeleTrader 2024-12-23 US chip firms' stock up on Biden's China probe
Newsfile Corp 2024-12-10 Railtown AI Accepted into the AMD Partner Network to Accelerate AI-driven Innovation
TeleTrader 2024-11-18 IBM unveils collaboration with AMD focused on AI
TeleTrader 2024-11-13 AMD cuts 4% of its global workforce
Newsfile Corp 2024-10-30 AI-powered Home Monitoring Data Presented at Academy 2024
TeleTrader 2024-10-29 AMD's Q3 revenue jumps 18% to $6.8B
TeleTrader 2024-10-29 Nasdaq surges 1% as tech sector leads gains
TeleTrader 2024-10-29 US open mostly lower ahead of major earnings
TeleTrader 2024-10-29 US mixed premarket ahead of big earnings
TeleTrader 2024-10-17 TSMC hits record high, surging 13% on profit growth
TeleTrader 2024-10-15 Nasdaq 100 drops by 1.3% on tech firms' losses
TeleTrader 2024-10-10 US stocks fall at close after latest CPI print
TeleTrader 2024-10-10 AMD unveils Ryzen AI PRO 300 Series processors for business PCs
TeleTrader 2024-09-19 Dow rises 650 pts, tops 42K for first time after Fed cut
TeleTrader 2024-09-19 Tesla shares up 5% amid broader tech rally after Fed rate cut
TeleTrader 2024-09-11 Oracle exec: AMD bearing well in Nvidia-dominated chip market
TeleTrader 2024-09-06 Dow loses 200 pts, Nasdaq slumps 2% on chips
GlobeNewswire 2024-09-01 Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire 2024-08-30 Opthea Reports Full-Year Financial Results and Business Updates
TeleTrader 2024-08-28 Dow down by 350 pts with tech sector in focus
GlobeNewswire 2024-08-28 PulseSight Therapeutics Confirms H2 2024 Conference Schedule
GlobeNewswire 2024-08-27 4DMT to Host 4D-150 Wet AMD Development Day on September 18, 2024
GlobeNewswire 2024-08-27 Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire 2024-08-27 EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire 2024-08-26 Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...